Mitchell Sinkler & Starr’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,234
Closed -$266K 192
2024
Q3
$266K Buy
4,234
+154
+4% +$8.98K 0.07% 145
2024
Q2
$244K Hold
4,080
0.06% 139
2024
Q1
$325K Sell
4,080
-2,149
-34% -$164K 0.08% 130
2023
Q4
$492K Buy
6,229
+410
+7% +$29.2K 0.09% 132
2023
Q3
$406K Hold
5,819
0.13% 90
2023
Q2
$402K Hold
5,819
0.11% 108
2023
Q1
$432K Buy
+5,819
New +$488K 0.13% 98
2013
Q3
Sell
-17,010
Closed -$973K 97
2013
Q2
$973K Buy
+17,010
New +$985K 0.21% 82

Other funds holding CVS

Mitchell Sinkler & Starr's CVS Position: Q4 2024 in Review

Mitchell Sinkler & Starr sold out of CVS Health (CVS) in Q4 2024, closing a stake of 4,234 shares — an estimated $266K sold.

Mitchell Sinkler & Starr first reported a position in CVS in Q2 2013 and held it in 8 quarters. The position peaked at $973K in Q2 2013. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Mitchell Sinkler & Starr reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Mitchell Sinkler & Starr sold 4,234 CVS Health shares in Q4 2024, an estimated $266K.
  • Mitchell Sinkler & Starr first reported a position in CVS Health in Q2 2013 and held it in 8 quarters.
  • Mitchell Sinkler & Starr's CVS Health position peaked at $973K in Q2 2013.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Mitchell Sinkler & Starr's 13F filing for Q4 2024, filed 12 Feb 2025.